Jianmin Pharmaceutical Group Co (SHSE:600976) Beginning Cash Position: ¥113 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600976 Jianmin Pharmaceutical Group Co Ltd SHSE:600976
65 GF Score
Price ¥29.62
GF Value ¥42.05
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Jianmin Pharmaceutical Group Co Beginning Cash Position?

Jianmin Pharmaceutical Group Co SHSE:600976 -0.64% 65 Beginning Cash Position is ¥113 Mil as of Mar. 2026. GuruFocus rates SHSE:600976 with a GF Score™ of 65/100 and a GF Value™ of ¥42.05 (Modestly Undervalued). The stock has 4 warning signs investors should review.

Jianmin Pharmaceutical Group Co's Beginning Cash Position for the quarter that ended in Mar. 2026 was ¥113 Mil.

Jianmin Pharmaceutical Group Co's quarterly Beginning Cash Position increased from Sep. 2025 (¥151 Mil) to Dec. 2025 (¥151 Mil) but then declined from Dec. 2025 (¥151 Mil) to Mar. 2026 (¥113 Mil).

Jianmin Pharmaceutical Group Co's annual Beginning Cash Position increased from Dec. 2023 (¥163 Mil) to Dec. 2024 (¥269 Mil) but then declined from Dec. 2024 (¥269 Mil) to Dec. 2025 (¥155 Mil).

Jianmin Pharmaceutical Group Co Beginning Cash Position Related Terms

Jianmin Pharmaceutical Group Co Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Jianmin Pharmaceutical Group Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Jianmin Pharmaceutical Group Co Beginning Cash Position Chart

Jianmin Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 65.28 279.98 163.21 268.59 155.39

Jianmin Pharmaceutical Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 155.39 263.46 150.82 150.83 112.53
SHSE:600976
65GF Score
Jianmin Pharmaceutical Group Co Ltd SHSE:600976
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Jianmin Pharmaceutical Group Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ¥113 Mil mean?
Jianmin Pharmaceutical Group Co (SHSE:600976) has a Beginning Cash Position of ¥113 Mil as of Mar. 2026. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jianmin Pharmaceutical Group Co and its competitors.
Is Jianmin Pharmaceutical Group Co's Beginning Cash Position too high?
Jianmin Pharmaceutical Group Co's current Beginning Cash Position is ¥113 Mil. Overall, Jianmin Pharmaceutical Group Co has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jianmin Pharmaceutical Group Co's Beginning Cash Position compare to ZTS?
Jianmin Pharmaceutical Group Co's Beginning Cash Position of ¥113 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Jianmin Pharmaceutical Group Co and its competitors. Jianmin Pharmaceutical Group Co's current Beginning Cash Position is ¥113 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jianmin Pharmaceutical Group Co stock overvalued right now?
Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co (SHSE:600976) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥42.05, compared to a current price of ¥29.62 — trading 29.6% below its estimated fair value. The current Beginning Cash Position is ¥113 Mil. Jianmin Pharmaceutical Group Co's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Jianmin Pharmaceutical Group Co (SHSE:600976), the current Beginning Cash Position is ¥113 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Jianmin Pharmaceutical Group Co (SHSE:600976) Overvalued in 2026?

Based on GuruFocus' analysis, Jianmin Pharmaceutical Group Co stock appears to be undervalued. The current stock price of ¥29.62 is trading 29.6% below its estimated GF Value™ of ¥42.05. GuruFocus considers Jianmin Pharmaceutical Group Co to be Modestly Undervalued.

Key valuation signals for SHSE:600976:

  • Beginning Cash Position: ¥113 Mil
  • GF Value™: ¥42.05 vs. price of ¥29.62 (29.6% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the SHSE:600976 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jianmin Pharmaceutical Group Co Business Description

Address No. 484 Parrot Avenue, Hanyang District, Wuhan, CHN, 430052
Jianmin Pharmaceutical Group Co Ltd is engaged in the manufacture and distribution of pharmaceutical products. It adheres to the core position of pediatric medicine, gynecological medicine, and special Chinese medicine, it offers products under Jianmin and Longmu brands.
65GF Score

Get the complete analysis for SHSE:600976

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥29.62
Price
¥42.05
GF Value